Formation of trihydroxyheptadecenoic acids, monohydroxyicosatrienoic acids, and prostaglandins from 8,11,14-icosatrienoic acid by adult and fetal aorta.
D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives / Q000378:metabolism*; D000527:Alprostadil; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D001095:Arachidonic Acids / Q000378:metabolism*; D002417:Cattle; D004837:Epinephrine / Q000494:pharmacology; D005231:Fatty Acids, Unsaturated / Q000378:metabolism*; D006538:Heptanoic Acids / Q000378:metabolism; D008706:Methemoglobin / Q000494:pharmacology; D011458:Prostaglandins E / Q000378:metabolism; D011460:Prostaglandins F / Q000378:metabolism
D001095:Arachidonic Acids; D005231:Fatty Acids, Unsaturated; D006538:Heptanoic Acids; D011458:Prostaglandins E; D011460:Prostaglandins F; C035510:15-hydroxy-8,11,13-eicosatrienoic acid; C035509:11-hydroxy-8,12,14-eicosatrienoic acid; C025560:12-hydroxy-8,10-heptadecadienoic acid; C035508:12-oxo-8,10-heptadecadienoic acid; D008706:Methemoglobin; D000527:Alprostadil; D015126:8,11,14-Eicosatrienoic Acid; C100006:prostaglandin F1; D004837:Epinephrine